loading
Überblick Nachrichten Preisverlauf Financials Forum Prognose

Finanzdaten der Hemab Therapeutics Holdings Inc-Aktie (COAG)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2026-06-30 2026-03-31
Periodenlänge 3 Monate 3 Monate
Operating Expenses
10.45%
26.08
 23.61
Operating Income/Loss
10.45%
-26.08
 -23.61
Income/Loss From Continuing Operations Before Tax
6.08%
-24.05
 -22.68
Income Tax Expense/Benefit
708.33%
0.097
 0.012
Net Income/Loss
6.45%
-24.15
 -22.69
Basic Average Shares
3,083%
30.11
 0.946
Diluted Average Shares
3,083%
30.11
 0.946
Basic Earnings Per Share
96.66%
-0.80
 -23.98
Diluted Earnings Per Share
96.66%
-0.80
 -23.98

Ähnlich wie COAG

ABSI ABSI
$8.25
price down icon 7.09%
ANAB ANAB
$46.61
price down icon 4.31%
RARE RARE
$14.54
price down icon 4.15%
AAPG AAPG
$15.37
price up icon 4.63%
KLRA KLRA
$11.25
price down icon 3.93%
KRSA KRSA
$32.38
price down icon 3.77%
In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters
Kapitalisierung:     |  Volumen (24h):